A patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 3, 2013, Pages 356-364

  Lin, Y T ^a   Chang, Y C ^a   Hui, R C Y ^a   Yang, C H ^a   Ho, H C ^a   Hung, S I ^b   Chung, W H ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B ANTIGEN; LAMOTRIGINE; OXCARBAZEPINE; PETROLATUM; PHENYTOIN;

ADULT; AGED; ARTICLE; ASIAN; CLINICAL ARTICLE; DRESS SYNDROME; DRUG SENSITIZATION; FEMALE; GENOTYPE; HUMAN; MALE; PATCH TEST; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

CARBAMAZEPINE; CASE-CONTROL STUDIES; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; PATCH TESTS; SKIN;

EID: 84874106931     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04418.x     Document Type: Article

References (31)

1. Barbaud A,. Drug patch tests in the investigation of cutaneous adverse drug reactions. Ann Dermatol Venereol 2009; 136: 635-644.
2. Barbaud A, Goncalo M, Bruynzeel D, Bircher A,. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001; 45: 321-328.
3. Wolkenstein P, Chosidow O, Flechet ML, et al. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis 1996; 35: 234-236.
4. Barbaud A,. Drug patch testing in systemic cutaneous drug allergy. Toxicology 2005; 209: 209-216.
5. Barbaud A,. Drug skin tests and systemic cutaneous adverse drug reactions: an update. Exp Rev Dermatol 2007; 2: 481-495.
6. Barbaud A, Reichert-Penetrat S, Trechot P, et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998; 139: 49-58.
7. Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P,. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002; 57: 45-51.
8. Lammintausta K, Kortekangas-Savolainen O,. The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol 2005; 152: 968-974.
9. Aberer W, Bircher A, Romano A, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003; 58: 854-863.
10. Alanko K,. Patch testing in cutaneous reactions caused by carbamazepine. Contact Dermatitis 1993; 29: 254-257.
11. Puig L, Nadal C, Fernandez-Figueras MT, Alomar A,. Carbamazepine-induced drug rashes: diagnostic value of patch tests depends on clinico-pathologic presentation. Contact Dermatitis 1996; 34: 435-437.
12. Santiago F, Goncalo M, Vieira R, Coelho S, Figueiredo A,. Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS). Contact Dermatitis 2010; 62: 47-53.
13. Chung WH, Hung SI, Hong HS, et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004; 428: 486.
14. Hung SI, Chung WH, Jee SH, et al. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics 2006; 16: 297-306.
15. Locharernkul C, Loplumlert J, Limotai C, et al. Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population. Epilepsia 2008; 49: 2087-2091.
16. Man CB, Kwan P, Baum L, et al. Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia 2007; 48: 1015-1018.
17. Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schroder W, Roujeau JC,. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 2002; 138: 1019-1024.
18. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2007; 156: 609-611.
19. Begovich AB, Erlich HA,. HLA typing for bone marrow transplantation. New polymerase chain reaction-based methods. JAMA 1995; 273: 586-591.
20. Tilanus MGJ, Hansen JA, Hurley CK, eds. Genomic Analysis of the Human MHC: DNA-Based Typing for HLA Alleles and Linked Polymorphisms (International Histocompatibility Working Group, Seattle). technical manual. 2002, Fred Hutchinson Cancer Research Center, Seattle, USA.
21. Gex-Collet C, Helbling A, Pichler WJ,. Multiple drug hypersensitivity- proof of multiple drug hypersensitivity by patch and lymphocyte transformation tests. J Investig Allergol Clin Immunol 2005; 15: 293-296.
22. Lee AY, Choi J, Chey WY,. Patch testing with carbamazepine and its main metabolite carbamazepine epoxide in cutaneous adverse drug reactions to carbamazepine. Contact Dermatitis 2003; 48: 137-139.
23. Wilkinson DS, Fregert S, Magnusson B, et al. Terminology of contact dermatitis. Acta Derm Venereol 1970; 50: 287-292.
24. Barbaud A, Trechot P, Reichert-Penetrat S, Commun N, Schmutz JL,. Relevance of skin tests with drugs in investigating cutaneous adverse drug reactions. Contact Dermatitis 2001; 45: 265-268.
25. Shear NH, Milpied B, Bruynzeel DP, Phillips EJ,. A review of drug patch testing and implications for HIV clinicians. AIDS 2008; 22: 999-1007.
26. Klein CE, Trautmann A, Zillikens D, Brocker EB,. Patch testing in an unusual case of toxic epidermal necrolysis. Contact Dermatitis 1995; 33: 448-449.
27. Hung SI, Chung WH, Liou LB, et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA 2005; 102: 4134-4139.
28. Vaillant L, Camenen I, Lorette G,. Patch testing with carbamazepine: reinduction of an exfoliative dermatitis. Arch Dermatol 1989; 125: 299.
29. Hirsch LJ, Arif H, Nahm EA, Buchsbaum R, Resor SR Jr, Bazil CW,. Cross-sensitivity of skin rashes with antiepileptic drug use. Neurology 2008; 71: 1527-1534.
30. Pasmans SG, Bruijnzeel-Koomen CA, van Reijsen FC,. Skin reactions to carbamazepine. Allergy 1999; 54: 649-650.
31. Troost RJ, Van Parys JA, Hooijkaas H, van Joost T, Benner R, Prens EP,. Allergy to carbamazepine: parallel in vivo and in vitro detection. Epilepsia 1996; 37: 1093-1099.